IMI1 – Call 1

IMI1 – Call 1 was launched on 30 April 2008 with the following topics:

  • Improve predictivity of immunogenicity
  • Non-genotoxic carcinogenesis
  • Expert systems for in silico toxicity prediction
  • Improved predictivity of non-clinical safety evaluation
  • Qualification of translational safety biomarkers
  • Strengthening the monitoring of benefit/risk
  • Islet cell research
  • Surrogate markers for vascular endpoints
  • Pain research
  • New tools for the development of novel therapies in psychiatric disorders
  • Neurodegenerative disorders
  • Understanding severe asthma
  • COPD patient reported outcomes
  • European medicines research training network
  • Safety sciences for medicines training programme
  • Pharmaceutical medicine training programme
  • Integrated medicines development programme
  • Pharmacovigilance training programme

More information on the topics can be found in IMI’s press release and in the Call text. Other relevant documents, including documents for applicants, the list of expert reviewers, and the independent observers’ reports of the evaluations, can be found on the IMI1 Call documents page

 

Projects

The projects resulting from IMI1 – Call 1 are:

  • EMTRAIN - European medicines research training network
    factsheet | website
  • eTOX - Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities
    factsheet | website
  • Eu2P - European programme in pharmacovigilance and pharmacoepidemiology
    factsheet | website
  • EUROPAIN - Understanding chronic pain and improving its treatment
    factsheet | website
  • IMIDIA - Improving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in diabetes 
    factsheet | website
  • MARCAR - Biomarkers and molecular tumour classification for non-genotoxic carcinogenesis
    factsheet | website
  • NEWMEDS - Novel methods leading to new medications in depression and schizophrenia
    factsheet | website
  • Pharma-Cog - Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development
    factsheet | website
  • Pharmatrain - Pharmaceutical medicine training programme
    factsheet | website
  • PRO-active - Physical activity as a crucial patient reported outcome in COPD
    factsheet
  • PROTECT - Pharmacoepidemiological research on outcomes of therapeutics by a European consortium
    factsheet | website
  • SAFE-T - Safer and faster evidence-based translation
    factsheet | website
  • SafeSciMET - European modular education and training programme in safety sciences for medicines
    factsheet | website
  • SUMMIT - Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools
    factsheet | website
  • U-BIOPRED - Unbiased biomarkers for the prediction of respiratory disease outcomes
    factsheet | website